These results point to a molecular mechanism of CA/NPY/Y1R/AP-1 signaling in the control of AMPH-mediated anorexia and may advance the medical research of anorectic and anti-obesity drugs. The gene discussed is AMPH; the disease is obesity due to melanocortin 4 receptor deficiency.